COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,629 Articles (22,913 medRxiv, 8,716 bioRxiv)

Most recent first Previous |  Page 1716: Articles 17151-17160  | Next

The health effects in the US of quarantine policies based on predicted individual risk of severe COVID-19 outcomes
Lovick, S. E., Dite, G. S., Allman, R.
10.1101/2021.03.21.21254065 — Posted: 2021-03-26
SARS-CoV-2 Acquisition and Immune Pathogenesis Among School-Aged Learners in Four K-12 Schools
Cooper, D. M., Messaoudi, i. R., Aizik, S., Camplain, R. L., Lopez, N. V., Ardo, J., Boden-Albala, B., Chau, C., Condon, C., Golden, C., Coimbra Ibraim, I., Jankeel, A., Kasper, K., Meyer, A., Stehli, A., Stephens, D., Weiss, M., Zulu, M. Z., Ulloa, E. R.
10.1101/2021.03.20.21254035 — Posted: 2021-03-26
A small number of early introductions seeded widespread transmission of SARS-CoV-2 in Quebec, Canada
Murall, C. L., Fournier, E., Galvez, J. H., N'Guessan, A., Reiling, S. J., Quirion, P.-O., Naderi, S., Roy, A.-M., Chen, S.-H., Stretenowich, P., Bourgey, M., Bujold, D., Gregoire, R., Lepage, P., St-Cyr, J., Willet, P., Dion, R., Charest, H., Lathrop, G. M., Roger, M., Bourque, G., Ragoussis, J., Shapiro, B. J., Moreira, S.
10.1101/2021.03.20.21253835 — Posted: 2021-03-26
Estimating the impact of interventions against COVID-19: from lockdown to vaccination
Thompson, J., Wattam, S.
10.1101/2021.03.21.21254049 — Posted: 2021-03-26
Simultaneous evaluation of antibodies that inhibit SARS-CoV-2 RBD variants with a novel competitive multiplex assay
Lopez, E., Haycroft, E. R., Adair, A., Mordant, F. L., O'Neill, M., Pymm, P., Redmond, S., Gherardin, N. A., Whearley, A. K., Juno, J. A., Selva, K. J., Davis, S., Harty, L., Purcell, D. F. J., Subbarao, K., Godfrey, D. I., Kent, S. J., Tham, W.-H., Chung, A. W.
10.1101/2021.03.20.21254037 — Posted: 2021-03-26
COVID-19: A need for new rather than repurposed antiviral drugs.
Kovacs, D., Davis, C., Cannon, P., McFarlane, M., Rainey, S. M., Pinto, R., Stewart, M. E., Szemiel, A. M., Taggart, A., Kohl, A., Marra, F., Thomson, E. C., Scott, J. T.
10.1101/2021.03.25.436935 — Posted: 2021-03-25
Target Capture Sequencing of SARS-CoV-2 Genomes Using the ONETest Coronaviruses Plus
Zhan, S. H., Alamouti, S. M., Kwok, B. S., Lee, M.-H., Khattra, J., Daneshpajouh, H., Houck, H. J., Rand, K. H.
10.1101/2021.03.25.437083 — Posted: 2021-03-25
Computational assessment of the spike protein antigenicity reveals diversity in B cell epitopes but stability in T cell epitopes across SARS-CoV-2 variants
Ge, A., Rioux, M., Kelvin, A. A.
10.1101/2021.03.25.437035 — Posted: 2021-03-25
Sulforaphane exhibits in vitro and in vivo antiviral activity against pandemic SARS-CoV-2 and seasonal HCoV-OC43 coronaviruses
Ordonez, A. A., Bullen, C. K., Villabona-Rueda, A. F., Thompson, E. A., Turner, M. L., Davis, S. L., Komm, O., Powell, J. D., D'Alessio, F. R., Yolken, R. H., Jain, S. K., Jones-Brando, L.
10.1101/2021.03.25.437060 — Posted: 2021-03-25
Freely accessible ready to use global infrastructure for SARS-CoV-2 monitoring
Maier, W., Bray, S., van den Beek, M., Bouvier, D., Coraor, N., Miladi, M., Singh, B., Rambla De Argila, J., Baker, D., Roach, N., Gladman, S., Coppens, F., Martin, D., Lonie, A., Gruning, B., Kosakovsky Pond, S., Nekrutenko, A.
10.1101/2021.03.25.437046 — Posted: 2021-03-25

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).